EUVIMEDEUVIMED entdecken
Crossref

DNMT inhibitor, 5-aza-2′-deoxycytidine mitigates di(2-ethylhexyl) phthalate-induced aggravation of psoriasiform inflammation in mice via reduction in global DNA methylation in dermal and peripheral compartments

Ali S Alfardan, Ahmed Nadeem, Sheikh F Ahmad, Naif O Al-Harbi, Mohammad Alqinyah, Sabry M Attia, Ahmed M El-Sherbeeny, Mohammad M Al-Harbi, Othman A Al-Shabanah, Khalid E Ibrahim, Khalid Alhazzani, Ahmed Z Alanazi

International Immunopharmacology · 2024-08 · 137 · 112503

DOI: 10.1016/j.intimp.2024.112503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024-08. Verfasst von Ali S Alfardan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia. Hauptthemen laut MEDLINE: DNA Methylation, Psoriasis, Decitabine, DNA (Cytosine-5-)-Methyltransferase 1. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is classified as an autoimmune disorder characterized by abnormal immune response leading to the development of chronic dermal inflammation. Most individuals have a genetic vulnerability that may be further influenced by epigenetic changes occurring due to multiple variables such as pollutant exposure. Epigenetic modifications such as DNA methylation possess a dynamic nature, enabling cellular differentiation and adaptation by controlling gene expression. Di(2-ethylhexyl) phthalate (DEHP) and psoriatic inflammation are known to cause modification of DNA methylation via DNA methyltransferase (DNMT). However, it is not known whether DEHP, a ubiquitous plasticizer affects psoriatic inflammation via DNMT modulation. Therefore, this study investigated the effect of DNMT inhibitor, 5-aza-2'-deoxycytidine (AZA) on DEHP-induced changes in the expression of DNMT1, global DNA methylation, and anti-/inflammatory parameters (p-STAT3, IL-17A, IL-6, iNOS, IL-10, Foxp3, Nrf2, HO-1) in the skin and the peripheral adaptive/ myeloid immune cells (CD4+ T cells/CD11b+ cells) in imiquimod (IMQ) model of psoriasiform inflammation. Further, psoriasis-associated clinical/histopathological features (ear thickness, ear weight, ear PASI score, MPO activity, and H&E staining of the ear and the back skin) were also analyzed in IMQ model. Our data show that IMQ-treated mice with DEHP exposure had increased DNMT1 expression and DNA methylation which was associated with elevated inflammatory (p-STAT3, IL-17A, IL-6, iNOS) and downregulated anti-inflammatory mediators (IL-10, Foxp3, Nrf2, HO-1) in the peripheral immune cells (CD4+ T cells/CD11b+ cells) and the skin as compared to IMQ-treated mice. Treatment with DNMT1 inhibitor caused reduction in inflammatory and elevation in anti-inflammatory parameters with significant improvement in clinical/histopathological symptoms in both IMQ-treated and DEHP-exposed IMQ-treated mice. In conclusion, our study shows strong evidence indicating that DNMT1 plays an important role in DEHP-induced exacerbation of psoriasiform inflammation in mice through hypermethylation of DNA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationPsoriasisDecitabineDNA (Cytosine-5-)-Methyltransferase 1SkinDiethylhexyl PhthalateAnimalsMiceMaleAnti-Inflammatory AgentsCytokinesDisease Models, AnimalMice, Inbred BALB CFemale

Stichwörter der Autor:innen

CD4+ T cellsDEHPDNA methylationDNMT1IL-17APsoriasis

Substanzen

DecitabineDNA (Cytosine-5-)-Methyltransferase 1Diethylhexyl PhthalateDnmt1 protein, mouseAnti-Inflammatory AgentsCytokines

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
  • Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia. Electronic address: anadeem@ksu.edu.sa.
  • Industrial Engineering Department, College of Engineering, King Saud University, Riyadh 11421, Saudi Arabia.
  • Department of Zoology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.

Förderung

  • King Saud University

Zitieren

APA

Alfardan, A. S., Nadeem, A., Ahmad, S. F., Al-Harbi, N. O., Alqinyah, M., Attia, S. M., El-Sherbeeny, A. M., Al-Harbi, M. M., Al-Shabanah, O. A., Ibrahim, K. E., Alhazzani, K., & Alanazi, A. Z. (2024). DNMT inhibitor, 5-aza-2′-deoxycytidine mitigates di(2-ethylhexyl) phthalate-induced aggravation of psoriasiform inflammation in mice via reduction in global DNA methylation in dermal and peripheral compartments. International Immunopharmacology, 137, 112503. https://doi.org/10.1016/j.intimp.2024.112503

Vancouver

Alfardan AS, Nadeem A, Ahmad SF, Al-Harbi NO, Alqinyah M, Attia SM, et al. DNMT inhibitor, 5-aza-2′-deoxycytidine mitigates di(2-ethylhexyl) phthalate-induced aggravation of psoriasiform inflammation in mice via reduction in global DNA methylation in dermal and peripheral compartments. International Immunopharmacology. 2024;137:112503. doi:10.1016/j.intimp.2024.112503

BibTeX
@article{Alfardan2024,
  author = {Alfardan, Ali S and Nadeem, Ahmed and Ahmad, Sheikh F and Al-Harbi, Naif O and Alqinyah, Mohammad and Attia, Sabry M and El-Sherbeeny, Ahmed M and Al-Harbi, Mohammad M and Al-Shabanah, Othman A and Ibrahim, Khalid E and Alhazzani, Khalid and Alanazi, Ahmed Z},
  title = {DNMT inhibitor, 5-aza-2′-deoxycytidine mitigates di(2-ethylhexyl) phthalate-induced aggravation of psoriasiform inflammation in mice via reduction in global DNA methylation in dermal and peripheral compartments},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {137},
  pages = {112503},
  doi = {10.1016/j.intimp.2024.112503}
}
Kostenlos starten →